Market Tracker

01/20 5:16pm ET

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

23.45
Delayed Data
As of Jan 20
 -0.05 / -0.21%
Today’s Change
9.51
Today|||52-Week Range
27.50
-7.13%
Year-to-Date
No recent news for Supernus Pharmaceuticals Inc.

Today’s Trading

Previous close23.50
Today’s open23.55
Day’s range23.10 - 23.80
Volume340,824
Average volume (3 months)635,306
Market cap$1.2B
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)-12.50%
Earnings growth (this year)+207.14%
Earnings growth (next 5 years)+50.00%
Revenue growth (last year)+18.34%
P/E ratio46.9
Price/Sales4.76
Price/Book9.69

Competitors

 Today’s
change
Today’s
% change
SGYPSynergy Pharmaceutic...-0.50-7.80%
INVAInnoviva Inc-0.03-0.28%
EBSEmergent BioSolution...+0.10+0.34%
DEPODepomed Inc-0.26-1.44%
Data as of 4:02pm ET, 01/20/2017

Financials

Next reporting dateMarch 8, 2017
EPS forecast (this quarter)$0.25
Annual revenue (last year)$144.4M
Annual profit (last year)$14.0M
Net profit margin9.70%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Secretary &
Director
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts